Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

4D Molecular Therapeutics (FDMT) Receivables - Other (2019 - 2022)

4D Molecular Therapeutics (FDMT) has disclosed Receivables - Other for 3 consecutive years, with $700000.0 as the latest value for Q4 2022.

  • Quarterly Receivables - Other changed 0.0% to $700000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $700000.0 through Dec 2022, changed 0.0% year-over-year, with the annual reading at $700000.0 for FY2022, 0.0% changed from the prior year.
  • Receivables - Other for Q4 2022 was $700000.0 at 4D Molecular Therapeutics, roughly flat from $700000.0 in the prior quarter.
  • The five-year high for Receivables - Other was $700000.0 in Q4 2021, with the low at $149000.0 in Q4 2019.
  • Average Receivables - Other over 3 years is $516333.3, with a median of $700000.0 recorded in 2021.
  • Peak annual rise in Receivables - Other hit 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
  • Over 3 years, Receivables - Other stood at $149000.0 in 2019, then surged by 369.8% to $700000.0 in 2021, then changed by 0.0% to $700000.0 in 2022.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $700000.0, $700000.0, and $149000.0 for Q4 2022, Q4 2021, and Q4 2019 respectively.